Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.
Shahid N, Craig T, Westerland M, Ashworth A, Ang M, D'Souza D, Sankreacha R, Fyles A, Milosevic M, Kong I; Cancer Care Ontario Radiation Treatment Gynecologic Oncology Community of Practice. Shahid N, et al. Among authors: kong i. Brachytherapy. 2018 Jul-Aug;17(4):660-666. doi: 10.1016/j.brachy.2018.03.003. Epub 2018 Apr 19. Brachytherapy. 2018. PMID: 29681500
The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis.
Qu XM, Velker VM, Leung E, Kwon JS, Elshaikh MA, Kong I, Logie NA, Mendez LC, van der Putten LJ, Donovan EK, Munkarah AR, Wiebe EM, Parra-Herran C, Warner A, Louie AV, D'Souza DP. Qu XM, et al. Among authors: kong i. Gynecol Oncol. 2018 May;149(2):283-290. doi: 10.1016/j.ygyno.2018.03.002. Epub 2018 Mar 12. Gynecol Oncol. 2018. PMID: 29544706
Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.
Olivotto IA, Whelan TJ, Parpia S, Kim DH, Berrang T, Truong PT, Kong I, Cochrane B, Nichol A, Roy I, Germain I, Akra M, Reed M, Fyles A, Trotter T, Perera F, Beckham W, Levine MN, Julian JA. Olivotto IA, et al. Among authors: kong i. J Clin Oncol. 2013 Nov 10;31(32):4038-45. doi: 10.1200/JCO.2013.50.5511. Epub 2013 Jul 8. J Clin Oncol. 2013. PMID: 23835717 Clinical Trial.
Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.
Peterson D, Truong PT, Parpia S, Olivotto IA, Berrang T, Kim DH, Kong I, Germain I, Nichol A, Akra M, Roy I, Reed M, Fyles A, Trotter T, Perera F, Balkwill S, Lavertu S, Elliott E, Julian JA, Levine MN, Whelan TJ; RAPID trial investigators. Peterson D, et al. Among authors: kong i. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):968-76. doi: 10.1016/j.ijrobp.2014.12.040. Int J Radiat Oncol Biol Phys. 2015. PMID: 25832689 Clinical Trial.
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer.
Donovan E, Reade CJ, Eiriksson LR, Pond GR, Arora N, Elit L, Memon S, Voruganti S, Patel M, Jimenez W, John M, Kong I. Donovan E, et al. Among authors: kong i. Cureus. 2018 Sep 29;10(9):e3387. doi: 10.7759/cureus.3387. Cureus. 2018. PMID: 30524915 Free PMC article.
A cosmesis outcome substudy in a prospective, randomized trial comparing radioguided seed localization with standard wire localization for nonpalpable, invasive, and in situ breast carcinomas.
Parvez E, Cornacchi SD, Hodgson N, Thoma A, Kong I, Foster G, Cheng J, Goldsmith CH, Dao D, Lovrics PJ. Parvez E, et al. Among authors: kong i. Am J Surg. 2014 Nov;208(5):711-718. doi: 10.1016/j.amjsurg.2014.05.030. Epub 2014 Aug 5. Am J Surg. 2014. PMID: 25201587 Clinical Trial.
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
482 results